Cardiovascular outcomes with GLP-1 receptor agonists

Vanessa Chapman, Associate Professional Lead for Medicines Information, Midlands & East, Midlands and East Medicines Advice Service (Midlands site) & UK Drugs in Lactation Advisory ServicePublished

This document reviews the evidence from the major cardiovascular clinical trials for GLP-1 receptor agonists.

Attachments